At the news
? BEARISHIMPACT 5/10 COURT-RULING filed Feb 8, 2026 at 19:00 ET
PTC Therapeutics suffered a setback as the District Court for the Northern District of California granted AcureX's motion to dismiss PTC's trade secret misappropriation lawsuit, finding that PTC failed to plausibly allege misappropriation of its trade secrets related to neurodegeneration treatments. The court granted leave to amend, so PTC can file an amended complaint by February 20, 2026.
- Court granted motion to dismiss all six causes of action for failure to state a claim
- PTC alleged misappropriation of trade secrets regarding 15-LO inhibitors and ferroptosis treatments
- Court found PTC did not plausibly allege misappropriation, relying on impermissible inevitable disclosure theory
- PTC granted leave to amend; amended complaint due by February 20, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access